A multicentre, prospective, randomised, double-masked, Phase 2 study evaluating the safety, tolerability and efficacy of topical AG-86893 in patients with Pterygium.
Trial Registry Number: NCT03533244
A not for profit organisation
A multicentre, prospective, randomised, double-masked, Phase 2 study evaluating the safety, tolerability and efficacy of topical AG-86893 in patients with Pterygium.
Trial Registry Number: NCT03533244
If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.